Status:
COMPLETED
Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS
Lead Sponsor:
Iakentro Fertility Centre
Collaborating Sponsors:
Aristotle University Of Thessaloniki
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
25-35 years
Brief Summary
The possibility to prevent the early ovarian hyperstimulation syndrome (OHSS) by doubling the daily dose of GnRH-antagonist in women stimulated with the antagonist protocol who are at risk for OHSS wa...
Eligibility Criteria
Inclusion
- Women stimulated with the antagonist protocol who are at risk of ovarian hyperstimulation syndrome
Exclusion
- Has chosen other preventive protocols (coasting and/or cryopreservation)were excluded
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT01477970
Start Date
February 1 2009
End Date
February 1 2010
Last Update
November 28 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.